GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bayer AG (OTCPK:BAYZF) » Definitions » EV-to-FCF

BAYZF (Bayer AG) EV-to-FCF : 9.44 (As of Dec. 14, 2024)


View and export this data going back to 2009. Start your Free Trial

What is Bayer AG EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Bayer AG's Enterprise Value is $54,744 Mil. Bayer AG's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2024 was $5,796 Mil. Therefore, Bayer AG's EV-to-FCF for today is 9.44.

The historical rank and industry rank for Bayer AG's EV-to-FCF or its related term are showing as below:

BAYZF' s EV-to-FCF Range Over the Past 10 Years
Min: -140.94   Med: 13.75   Max: 4266.26
Current: 9.8

During the past 13 years, the highest EV-to-FCF of Bayer AG was 4266.26. The lowest was -140.94. And the median was 13.75.

BAYZF's EV-to-FCF is ranked better than
80.18% of 550 companies
in the Drug Manufacturers industry
Industry Median: 25.795 vs BAYZF: 9.80

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2024-12-14), Bayer AG's stock price is $20.74. Bayer AG's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 was $-1.049. Therefore, Bayer AG's PE Ratio (TTM) for today is At Loss.


Bayer AG EV-to-FCF Historical Data

The historical data trend for Bayer AG's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bayer AG EV-to-FCF Chart

Bayer AG Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 18.93 31.04 31.52 19.01 27.67

Bayer AG Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -69.91 27.67 5.06 2.82 4.45

Competitive Comparison of Bayer AG's EV-to-FCF

For the Drug Manufacturers - General subindustry, Bayer AG's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bayer AG's EV-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Bayer AG's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Bayer AG's EV-to-FCF falls into.



Bayer AG EV-to-FCF Calculation

Bayer AG's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=54744.043/5796.281
=9.44

Bayer AG's current Enterprise Value is $54,744 Mil.
Bayer AG's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $5,796 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Bayer AG  (OTCPK:BAYZF) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Bayer AG's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=20.74/-1.049
=At Loss

Bayer AG's share price for today is $20.74.
Bayer AG's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.049.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Bayer AG EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Bayer AG's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Bayer AG Business Description

Address
Kaiser-Wilhelm-Allee 1, Leverkusen, NW, DEU, 51368
Bayer is a German healthcare and agriculture conglomerate. Healthcare provides close to half of the company's sales and includes pharmaceutical drugs as well as vitamins and other consumer healthcare products. The firm also has a crop science business that includes seeds, pesticides, herbicides, and fungicides, which was expanded through its 2018 acquisition of Monsanto.

Bayer AG Headlines

From GuruFocus

Q3 2022 Bayer AG Earnings Press Conference Transcript

By GuruFocus Research 02-12-2024

Q2 2024 Bayer AG Earnings Call Transcript

By GuruFocus Research 08-07-2024

Q3 2024 Bayer AG Earnings Call Transcript

By GuruFocus News 11-13-2024

Q4 2023 Bayer AG Earnings Call Transcript

By GuruFocus Research 03-06-2024

Bayer AG Pharmaceuticals R&D Event Transcript

By GuruFocus Research 02-12-2024

Q3 2023 Bayer AG Earnings Call Transcript

By GuruFocus Research 02-12-2024